Gene · 2621
Papers3,604
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,604
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unveiling the impact of bisphenol a exposure on gene expression and immune response in diabetic nephropathy through integrative toxicogenomics and molecular dynamics approaches. | Diabetol Metab Syndr | 2025 | 40826470 | PubTator, text mining | PubMed |
| TRIM31 triggers colorectal carcinogenesis and progression by maintaining YBX1 protein stability through ubiquitination modification. | Cell Death Dis | 2025 | 40819060 | PubTator, text mining | PubMed |
| Signaling networks and MiRNA crosstalk in ovarian cancer chemoresistance. | J Ovarian Res | 2025 | 40813689 | PubTator, text mining | PubMed |
| Plasma extracellular vesicle surface-located GAS6/PROS1 and CD39/CD73 attenuate inflammation. | Cell Rep | 2025 | 40751911 | PubTator, text mining | PubMed |
| ApoBDs: a paradigm shift from cellular debris to therapeutic vehicles. | Front Endocrinol (Lausanne) | 2025 | 40747304 | PubTator, text mining | PubMed |
| Calcium binding by γ-carboxyglutamic acid: it takes two to tether. | Res Pract Thromb Haemost | 2025 | 40746440 | PubTator, text mining | PubMed |
| Comprehensive human proteome profiles across a 50-year lifespan reveal aging trajectories and signatures. | Cell | 2025 | 40713952 | PubTator, text mining | PubMed |
| Single-cell genomics reveals transcriptional heterogeneity and cellular crosstalk in salivary gland fibrosis. | J Dent Sci | 2025 | 40654481 | PubTator, text mining | PubMed |
| 4'-hydroxywogonin inhibits oral squamous cell carcinoma progression by targeting Gas6/Axl signaling axis. | J Dent Sci | 2025 | 40654434 | PubTator, text mining | PubMed |
| AXL in cardiovascular diseases: Pathophysiological insights and clinical perspectives. | Pathol Res Pract | 2025 | 40652749 | PubTator, text mining | PubMed |
| eEF2K is a poor prognostic factor and novel molecular target in pancreatic cancer: regulating tumor growth and progression via the tumor microenvironment. | Cell Death Dis | 2025 | 40624025 | PubTator, text mining | PubMed |
| Proteome-wide Mendelian randomization and colocalization analysis identify therapeutic targets for stroke. | BMC Neurol | 2025 | 40596960 | PubTator, text mining | PubMed |
| Phase 1b/2 study of batiraxcept alone and in combination with cabozantinib with or without nivolumab for advanced clear cell renal cell carcinoma. | Oncologist | 2025 | 40549043 | PubTator, text mining | PubMed |
| Protective effects of Ginkgolide B on myocardial ischemia reperfusion injury: role of the GAS6/Axl signaling pathway. | Chem Biol Interact | 2025 | 40541647 | PubTator, text mining | PubMed |
| Cerebrospinal Fluid Biomarkers in Opioid Dependence: Evidence of Neuroimmune Activation and Ion Composition Changes, Without Alteration in Orexin-A. | Addict Biol | 2025 | 40454659 | PubTator, text mining | PubMed |
| Exploring the Link Between Vitamin K and Depression: A Systematic Review. | Medicina (Kaunas) | 2025 | 40428819 | PubTator, text mining | PubMed |
| VPS9D1-AS1 antisense therapy via lipid nanoparticles reprograms cold tumors and enhances immunotherapy in colorectal cancer. | J Control Release | 2025 | 40412657 | PubTator, text mining | PubMed |
| Identification of lncRNAs involved in the hair follicle cycle transition of cashmere goats in response to photoperiod change. | BMC Genomics | 2025 | 40375123 | PubTator, text mining | PubMed |
| AXL and SRC in clear cell renal cell carcinoma: absence of mutations, rare alternative splicing events, but association of protein expression with poor prognosis. | J Pathol Clin Res | 2025 | 40260977 | PubTator, text mining | PubMed |
| AXL Tyrosine Kinases: A Growing Isoform Family That Promotes Cancer Pathogenesis. | Cancer Res | 2025 | 40245163 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2621/papers?page=8